Although children's books often include fantasy, research suggests that children do not learn as well from fantastical stories as from realistic ones. The current studies investigated whether the type of fantasy matters, in effect testing two possible mechanisms for fantasy's interference. Across two studies, 110 5-year-olds were read different types of fantastical stories containing a problem and then were asked to solve an analogous problem in a real lab setting. Children who were read a minimally fantastical version of the story, in which the story occurred on another planet "that looked just like Earth," were no more likely to transfer the solution than children who heard a story that was slightly more fantastical in that the story occurred on another planet and that planet looked different from Earth (e.g., orange grass, a green sky). In contrast, significantly higher rates of learning were observed when the story contained those elements and two physically impossible events (e.g., walking through walls). Furthermore, this improvement was obtained only when the impossible events preceded, and not when they followed, the educational content. Although fantasy may sometimes detract from learning (as other research has shown), these new studies suggest that minimal fantasy does not and that particular types of fantasy may even increase learning. We propose that the mechanism for this may be that a small dose of impossible events induces deeper processing of the subsequent events in the story.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jecp.2021.105212 | DOI Listing |
PLoS One
January 2025
Department of Computer Engineering, Sharif University of Technology, Tehran, Iran.
Neuromorphic engineering has emerged as a promising avenue for developing brain-inspired computational systems. However, conventional electronic AI-based processors often encounter challenges related to processing speed and thermal dissipation. As an alternative, optical implementations of such processors have been proposed, capitalizing on the intrinsic information-processing capabilities of light.
View Article and Find Full Text PDFDrug Discov Ther
January 2025
Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Cancer Genomics Proteomics
December 2024
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Background/aim: Neurofibromatosis type 1 (NF1) is a genetic disorder with an incidence of approximately one in 3,000. More than half of the patients have new de novo pathogenic variants of the NF1 gene. In most family cases, all family members share an identical NF1-variant.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
January 2025
Service of Neurology, Hospital Clinic, Barcelona, Spain.
Anti-IgLON5 disease was identified 10 years ago, thanks to the discovery of IgLON5 antibodies and the joint effort of specialists in sleep medicine, neuroimmunology, and neuropathology. Without this collaboration, it would have been impossible to untangle fundamental aspects of this disease. After the seminal description in 2014, today there is growing evidence that most patients present a chronic progressive course with gait instability, abnormal movements, bulbar dysfunction, and a sleep disorder characterized by nonrapid eye movement and REM parasomnias, and obstructive sleep apnea with stridor.
View Article and Find Full Text PDFSAGE Open Med
December 2024
Teleflex Incorporated, Morrisville, NC, USA.
Background: To demonstrate the safety and performance of the Arrow EZ-IO Intraosseous Vascular Access System, particularly in the pediatric patient population, a retrospective observational study was conducted in 2021 and 2022.
Methods: Following study design, IRB approval, and investigator selection, data were collected for all patients needing intraosseous access-adult and pediatric. The primary endpoint was the success rate for achieving intraosseous access; the secondary endpoint was the rate of adverse events.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!